Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Johnson and Johnson
Daiichi Sankyo
Harvard Business School

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,049,672

« Back to Dashboard

Title: 4-Methyl-5-imidazolylmethylthioethylamine and -S-methylisothiourea
Abstract:The compounds are heterocyclic thioalkyl-, aminoalkyl- and oxyalkylguanidines which are inhibitors of histamine activity, particularly inhibitors of H-2 histamine receptors.
Inventor(s): Durant; Graham John (Welwyn Garden City, EN), Emmett; John Colin (Codicote, EN), Ganellin; Charon Robin (Welwyn Garden City, EN)
Assignee: Smith Kline & French Laboratories Limited (Welwyn Garden City, EN)
Filing Date:Mar 17, 1976
Application Number:05/667,738
Claims:1. A compound of the formula: ##STR15##

2. A compound of the formula: ##STR16##

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Federal Trade Commission
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.